Summit Therapeutics sells antibiotic asset ridinilazole for up to $105M

Go back to Summit Therapeutics sells antibiotic asset ridinilazole for up to $105M
Stratcomm Media, Ltd. (NASDAQ: SMMT) Delayed: 17.85 +0.13 (0.73%)
Previous Close $17.72    52 Week High $19.75 
Open $17.74    52 Week Low $4.26 
Day High $17.87    P/E N/A 
Day Low $17.31    EPS $0.00 
Volume 13,060,178